Transmembrane mucin 1: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 11: | Line 11: | ||
| Subspecial = | | Subspecial = | ||
| Pattern = | | Pattern = | ||
| Positive = most | | Positive = most [[adenocarcinoma]]s | ||
| Negative = | | Negative = [[basal cell carcinoma]] | ||
| Other = | | Other = | ||
}} | }} | ||
| Line 29: | Line 29: | ||
==See also== | ==See also== | ||
*[[Immunohistochemistry]]. | *[[Immunohistochemistry]]. | ||
*[[AE1/AE3]]. | |||
*[[Z622]]. | |||
==References== | ==References== | ||
{{Reflist|1}} | {{Reflist|1}} | ||
==External links== | |||
*[http://www.nordiqc.org/Epitopes/EMA/EMA.htm EMA (nordiqc.org)]. | |||
[[Category:Immunohistochemistry]] | [[Category:Immunohistochemistry]] | ||